ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 74 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $95,351,000 | -50.8% | 1,783,935 | +4.0% | 0.02% | -51.1% |
| Q4 2015 | $193,833,000 | -8.4% | 1,715,796 | -4.5% | 0.04% | -18.2% |
| Q3 2015 | $211,546,000 | +48.6% | 1,797,176 | -2.3% | 0.06% | +61.8% |
| Q2 2015 | $142,387,000 | +40.5% | 1,838,909 | +5.0% | 0.03% | +41.7% |
| Q1 2015 | $101,337,000 | +79.2% | 1,751,717 | -0.1% | 0.02% | +71.4% |
| Q4 2014 | $56,534,000 | +42.1% | 1,752,982 | +7.8% | 0.01% | +27.3% |
| Q3 2014 | $39,795,000 | +72.1% | 1,626,258 | +24.7% | 0.01% | +57.1% |
| Q2 2014 | $23,124,000 | -4.0% | 1,304,235 | +8.3% | 0.01% | 0.0% |
| Q1 2014 | $24,096,000 | +24.6% | 1,204,181 | +4.4% | 0.01% | +16.7% |
| Q4 2013 | $19,346,000 | +57.5% | 1,152,930 | -0.3% | 0.01% | +50.0% |
| Q3 2013 | $12,280,000 | +118.7% | 1,156,322 | +15.1% | 0.00% | +100.0% |
| Q2 2013 | $5,616,000 | – | 1,004,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |